MedPath

Study to help in estimation of Jaundice in Neonates

Phase 1
Registration Number
CTRI/2019/03/017896
Lead Sponsor
eospec Labs
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

The details given are for the Neonate samples.

We will also be collecting samples from healthy adult individuals.

Exclusion Criteria

Patients with Anemia and Polycythemia will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
After completion of the study, we will be able to develop and fine-tune a computer algorithm to analyze bilirubin in whole blood, especially that of neonates. This algorithm will go into a point of care device we are developing and help diagnose Jaundice more effectively.Timepoint: The measurements will be made and recorded within 24 hrs of sample withdrawal from the body. <br/ ><br>No results about measurements will be delivered to the volunteers after the samples are measured. <br/ ><br>The results will be recorded and used by the researchers to develop their device.
Secondary Outcome Measures
NameTimeMethod
ATimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath